Mountcastle David 4

What Happened

• David Mountcastle, Chief Financial Officer of Privia Health Group (PRVA), exercised a total of 13,058 stock options (5,361 on 2026-02-26 and 7,697 on 2026-02-27) at $2.00 per share (total cost $26,116) and sold those shares in open-market transactions for aggregate proceeds of $326,835 (sales at roughly $25.00–$25.19 per share).
• The filing shows multiple related "exercise/conversion" entries reported at $0.00 for the same number of shares; the combined effect in the filing is an exercise followed by sale (i.e., shares were turned into cash through immediate sale).

Key Details

• Transaction dates: 2026-02-26 and 2026-02-27; filing date: 2026-03-02 (filed within the normal Form 4 reporting window).
• Exercise details: 13,058 options exercised at $2.00 per share (total cash cost $26,116).
• Sales: 13,058 shares sold for total proceeds of $326,835 (reported weighted-average sale prices ~$25.00–$25.19; see footnotes F2 and F3 for price ranges).
• Shares owned after the transactions: not specified in the information provided.
• Notable footnotes: F1 notes at least one sale was made under a pre-established Rule 10b5-1 trading plan; F4 states all stock options were fully vested and exercisable. Several exercise/conversion lines show $0.00 as the reported price for those derivative disposals (listed in the filing).

Context

• This is an executive (CFO) option exercise followed by open-market sale — a common pattern often described as a cashless exercise/net sale. The filing lists both the option exercise entries (M) and the corresponding sales (S).
• The presence of a 10b5-1 plan for part of the activity (F1) indicates at least some sales were executed under a predetermined plan.
• The transactions are reported factually here; they do not by themselves indicate management’s future view of the company.